Key Highlights
- Wisp announces new fertility products and services to assist women in getting pregnant.
- 1 in 5 women of childbearing age struggle to conceive, highlighting the importance of accessible fertility care.
- Partnerships with Proov and PherDal offer at-home hormone testing and insemination kits.
- New services include fertility consultations, at-home blood draws, and prescription medications.
Source: Business Wire
Notable Quotes
- “As a company, we’re obsessed with listening to our patients and building new solutions that fit their needs, and launching fertility is addressing two major pain points our patients face. A recent survey we conducted found that 70% of our patients were interested in more education on fertility and products that help those trying to conceive.” — Monica Cepak, CEO at Wisp
- “Fertility is a very personal journey for each patient. Wisp is working to make it easier to access the tools, treatments, and information you need to feel empowered and knowledgeable about your options.” — Dr. Jillian LoPiano, Chief Health Officer at Wisp
SoHC's Take
Wisp’s launch of a new fertility vertical marks a significant step forward in accessible reproductive healthcare. By addressing the needs of women struggling to conceive, Wisp is providing affordable alternatives to expensive IVF treatments. The partnerships with Proov and PherDal further enhance Wisp’s offerings, making at-home fertility care more comprehensive. This initiative not only meets the demand for more fertility education and resources but also supports women during a crucial phase of their reproductive journey, making it easier and less stressful to navigate.
